Bio
Greg Kaufman is a clinical and senior research fellow in the divisions of Hematology and Medical Oncology at Stanford University and Stanford Healthcare. His research focus lies within the disease areas of dysproteinemias and lymphoproliferative disorders. His ongoing work is focused on clinical trials evaluating novel treatments for multiple myeloma, AL amyloidosis, and low grade lymphomas.

Bio
I am currently working on several projects to understand the control of intestinal and colorectal cancer stem cell biology. Stem cells of the intestinal tract give rise to the surface lining of the small and large intestines, and must continuously produce new cells to replace those shed into the lumen throughout the lifespan. When mutations accumulate in these intestinal stem cells, they can grow uncontrollably into benign polyps or colorectal cancers. I have focused my efforts on understanding the molecular mechanisms that regulate stem cell activity in the intestine, and applying this knowledge to gain insight into how these same pathways can control the activity of cancer stem cells.